MetaCap

Spectral AI Inc. Class A (MDAI)

NASDAQ: MDAIHealth CareMedical/Dental InstrumentsUSD

1.04-0.27 (-20.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MDAI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$33.47M
EPS (TTM)
-$0.30
52-week range
1.00 – 2.97
Day range
1.00 – 1.28
Volume / Avg
944.28K / 142.00K
Beta
—

52-week range

$1.00$2.97

MDAI stock today

On Nov 20, MDAI ended the session at $1.04, shedding $0.27 (20.61%), versus the S&P 500's 3.70% decline. Volume was 6.7x the average at 944.28K shares, a sign of unusually heavy trading. Shares are 65.0% below their 52-week high of $2.97, set on May 26, 2026 and 4.0% above the 52-week low of $1.00, near the bottom of the past year's range.

MDAI is down 26.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 27.3%. Spectral AI has posted a net loss over the last twelve months (EPS of -$0.30), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Spectral AI

Company profile

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images.

Industry
Medical/Dental Instruments
CEO
Mr. Vincent Stanley Capone Esq.
Headquarters
Dallas, TX
Employees
65
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, Spectral AI generated $19.6 million in revenue, down 33.6% from fiscal 2024, its first annual decline since 2023. Spectral AI reported a net loss of $7.6 million, compared with a loss of $15.2 million a year earlier. Gross margin was 45.4% (up from 44.9%) and operating margin -43.8%.

Spectral AI annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$19.65M$29.58M$18.06M$25.37M—
Growth-33.57%+63.83%-28.82%——
Net income$-7.57M$-15.16M$-20.85M$-2.91M$-2.15M
EPS (diluted)$-0.29$-0.85$-1.48$-0.22—

Analyst forecast

Forecast

Consensus (1 analysts)

none

Avg. price target

$5.11+391.35%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $4.00High $6.25

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$-0.13 vs $-0.14
Surprise
+7.14%

MDAI news

All MDAI news

Spectral AI peers

Health Care sector
MDAI peer companies
CompanyPrice% ChgMarket capCompare
TELATELA Bio Inc.0.6885-5.27%$31.11Mvs MDAI
SRTSSensus Healthcare Inc.2.26-4.24%$37.20Mvs MDAI
XTNTXtant Medical Holdings Inc.0.21-2.82%$29.49Mvs MDAI
NSPRInspireMD Inc.0.54-12.97%$29.23Mvs MDAI
NEPHNephros Inc.2.61-8.10%$28.37Mvs MDAI
DXRDaxor Corporation7.45-7.33%$43.49Mvs MDAI
PLRZPolyrizon Ltd.9.31-8.42%$22.61Mvs MDAI
DAVIDavion Healthcare Plc0.9001-9.99%$22.50Mvs MDAI

Indexes, lists and sector

Spectral AI stock FAQ

What is Spectral AI's stock price today?

MDAI last traded at $1.04 as of Nov 20, 4:00 PM EST, down 20.61% on the day. Prices are delayed at least 15 minutes.

Who is Spectral AI's CEO?

Mr. Vincent Stanley Capone Esq. is the chief executive officer of Spectral AI Inc. Class A, which has about 65 employees.

What is the MDAI 52-week high?

The 52-week high for MDAI is $2.97 and the 52-week low is $1.00. The stock is currently 65.0% below its high.

Compare MDAI